SIGNPATH PHARMA, INC. Active Patents
19 granted patents the USPTO still lists as patented, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2023-10-04: Application 18480678; Invention Dosing Regimens for Treatment of Proliferative Disorders; Applicant Signpath Pharma Inc.; Status Patented Case.
- 2022-09-22: Application 17950898; Invention Cardioprotective Lipid and Method of Use; Applicant Signpath Pharma, Inc.; Status Patented Case.
- 2021-11-05: Application 17520287; Invention CARDIOPATHY-REDUCING PHOSPHODIESTER LIPIDS; Applicant Signpath Pharma, Inc.; Status Patented Case.
- 2021-03-03: Application 17191214; Invention CARDIOPATHY-REDUCING PHOSPHODIESTER LIPIDS; Applicant Signpath Pharma, Inc.; Status Patented Case.
| Filed | Application | Invention | Applicant | Status | Granted | Patent | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|---|---|
| 2023-10-04 | 18480678 | Dosing Regimens for Treatment of Proliferative Disorders | Signpath Pharma Inc. | Patented Case | 2026-02-17 | 12551436 | US20240050372A1 | Peter Sordillo | United States | RONEY, CELESTE A |
| 2022-09-22 | 17950898 | Cardioprotective Lipid and Method of Use | Signpath Pharma, Inc. | Patented Case | 2026-05-05 | 12617809 | US20230042703A1 | James McChesney Annie Bouchard Saravanan Kappusamy John Kallikat Augustine Daniel Emil Levy Dany Salvail | United States Canada India India United States Canada | O DELL, DAVID K |
| 2021-11-05 | 17520287 | CARDIOPATHY-REDUCING PHOSPHODIESTER LIPIDS | Signpath Pharma, Inc. | Patented Case | 2023-09-05 | 11746119 | US20220056057A1 | James McChesney Annie Bouchard Saravanan Kappusamy John Kallikat Augustine Daniel Emil Levy | United States Canada India India United States | O DELL, DAVID K |
| 2021-03-03 | 17191214 | CARDIOPATHY-REDUCING PHOSPHODIESTER LIPIDS | Signpath Pharma, Inc. | Patented Case | 2023-05-09 | 11643424 | US20210198294A1 | James McChesney Annie Bouchard Saravanan Kappusamy John Kallikat Augustine Daniel Emil Levy | United States Canada India India United States | O DELL, DAVID K |
| 2020-10-05 | 17045431 | Dosing Regimens for Treatment of Proliferative Disorders | Signpath Pharma, Inc. | Patented Case | 2023-11-14 | 11813356 | US20210161815A1 | Peter Sordillo | United States | RONEY, CELESTE A |
| 2019-06-26 | 16452858 | CARDIOPATHY-REDUCING PHOSPHODIESTER LIPIDS | Signpath Pharma, Inc. | Patented Case | 2021-04-13 | 10975111 | US20190389888A1 | James McChesney Annie Bouchard Saravanan Kappusamy John Kallikat Augustine Daniel Emil Levy | United States Canada India India United States | O DELL, DAVID K |
| 2019-06-05 | 16432498 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | Signpath Pharma, Inc. | Patented Case | 2024-06-11 | 12004868 | US20190320975A1 | Lawrence Helson George M. Shopp Annie Bouchard | United States United States Canada | KISHORE, GOLLAMUDI S |
| 2017-10-19 | 15788683 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SignPath Pharma Inc. | Patented Case | 2019-03-26 | 10238602 | US20180055770A1 | Lawrence Helson George M. Shopp Annie Bouchard Muhammed Majeed | United States United States Canada United States | VU, JAKE MINH |
| 2017-05-17 | 15597411 | LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT | SignPath Pharma Inc. | Patented Case | 2019-07-23 | 10357458 | US20170246110A1 | Lawrence Helson | United States | RONEY, CELESTE A |
| 2017-04-24 | 15494932 | PREVENTION OF DRUG-INDUCED ATRIO-VENTRICULAR BLOCK | SignPath Pharma Inc. | Patented Case | 2023-11-07 | 11806401 | US20170312366A1 | Lawrence Helson Annie Bouchard | United States Canada | VU, JAKE MINH |
| 2017-01-11 | 15403831 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SignPath Pharma Inc. | Patented Case | 2019-07-16 | 10349884 | US20170119802A1 | Lawrence Helson George M. Shopp Annie Bouchard | United States United States Canada | RONEY, CELESTE A |
| 2016-11-09 | 15347381 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SignPath Pharma Inc. | Patented Case | 2018-11-06 | 10117881 | US20170095489A1 | Lawrence Helson | United States | RONEY, CELESTE A |
| 2016-10-19 | 15297901 | PROTECTIVE EFFECT OF DMPC, DMPG, DMPC/ | SignPath Pharma Inc. | Patented Case | 2019-10-22 | 10449193 | US20170035887A1 | Lawrence Helson George M. Shopp Annie Bouchard Muhammed Majeed | United States United States Canada United States | VU, JAKE MINH |
| 2016-09-14 | 15265574 | TREATMENT FOR GLIOBLASTOMA | SignPath Pharma Inc. | Patented Case | 2019-11-26 | 10485768 | US20170079934A1 | Laura A. Sordillo Peter P. Sordillo Lawrence Helson | United States United States United States | RONEY, CELESTE A |
| 2016-03-11 | 15068300 | LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT | SignPath Pharma Inc. | Patented Case | 2020-04-14 | 10617639 | US20160193149A1 | Lawrence Helson | United States | SHOMER, ISAAC |
| 2014-12-18 | 14575644 | LIPOSOMAL MITIGATION OF DRUG-INDUCED INHIBITION OF THE CARDIAC IKR CHANNEL | SignPath Pharma Inc. | Patented Case | 2020-01-14 | 10532045 | US20150164878A1 | Lawrence Helson George M. Shopp Annie Bouchard | United States United States Canada | RONEY, CELESTE A |
| 2014-05-13 | 14276068 | LIPOSOMAL CURCUMIN FOR TREATMENT OF DISEASES | SignPath Pharma Inc. Board of Regents, The University of Texas System | Patented Case | 2018-06-26 | 10004687 | US20140322303A1 | Razelle Kurzrock Lan Li Kapil Mehta Bharat Bhushan Aggarawal Lawrence Helson | United States United States United States United States United States | SHOMER, ISAAC |
| 2014-05-02 | 14268376 | LIPOSOMAL MITIGATION OF DRUG-INDUCED LONG QT SYNDROME AND POTASSIUM DELAYED-RECTIFIER CURRENT | SignPath Pharma Inc. | Patented Case | 2017-06-20 | 9682041 | US20140242156A1 | Lawrence Helson | United States | RONEY, CELESTE A |
| 2013-08-31 | 14016056 | CURCUMIN-ER, A LIPOSOMAL-PLGA SUSTAINED RELEASE NANOCURCUMIN FOR MINIMIZING QT PROLONGATION FOR CANCER THERAPY | SignPath Pharma Inc. University of North Texas Health Science Center | Patented Case | 2015-09-22 | 9138411 | US20140065061A1 | Amalendu Prakash Ranjan Anindita Mukerjee Jamboor K. Vishwanatha Lawrence Helson | United States United States United States United States | DICKINSON, PAUL W |